Fig. 3From: HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patientsDiagnostic performance of CA125, HE4 and ROMA for detection of Stage III and Stage IV ovarian cancer in premenopausal (A) and postmenopausal (B) patientsBack to article page